EKF Diagnostics Holdings plc
EKF.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.29 | 0.07 | -0.66 | -0.02 |
| FCF Yield | 3.66% | 4.11% | 5.02% | 0.22% |
| EV / EBITDA | 18.01 | 19.53 | 21.31 | 31.73 |
| Quality | ||||
| ROIC | 2.66% | 6.13% | 2.84% | 6.61% |
| Gross Margin | 50.20% | 49.37% | 47.84% | 48.25% |
| Cash Conversion Ratio | 2.53 | 1.39 | 3.81 | 1.79 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.37% | -2.28% | 9.06% | 15.49% |
| Free Cash Flow Growth | -12.02% | -20.88% | 1,935.14% | 132.04% |
| Safety | ||||
| Net Debt / EBITDA | -2.64 | -2.32 | -1.54 | -0.82 |
| Interest Coverage | 72.67 | 56.93 | 26.14 | 64.53 |
| Efficiency | ||||
| Inventory Turnover | 1.61 | 1.71 | 1.61 | 1.52 |
| Cash Conversion Cycle | 39.86 | 65.99 | 46.71 | 82.33 |